| Bioactivity | Cdk2/Cyclin Inhibitory Peptide I (Tat-LFG), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1]. |
| Invitro | Cdk2/Cyclin Inhibitory Peptide I (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: |
| Name | Cdk2/Cyclin Inhibitory Peptide I |
| CAS | 237392-84-6 |
| Shortening | YGRKKRRQRRRGPVKRRLFG |
| Formula | C111H196N48O23 |
| Molar Mass | 2571.05 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Cdk2/Cyclin Inhibitory Peptide I
CAS: 237392-84-6 F: C111H196N48O23 W: 2571.05
Cdk2/Cyclin Inhibitory Peptide I (Tat-LFG), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner.
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.